Immtech Reports Fiscal Third Quarter 20... (December 31 ...)

(Date:12/1/2009)...l Research Building (CRB), at the University of Mi...r its sustainability components. The building was ....S. Green Building Council and verified by the Gre...s the nation,s preeminent program for the design, ...Having a LEED certified building means we,re doing...

(Date:12/1/2009)...ewswire-FirstCall/ -- Air Products (NYSE: APD ) ...ed sale of the assets of its polyurethane pre-poly...nd Versathane® tradenames to COIM USA Inc., a...micals producer COIM SpA. ,, Included in the s...ulsboro, N.J. Terms of the agreement are not being...

(Date:12/1/2009)...courages Older Persons and Healthcare Workers to G...on Authority Data ,, HARRISBURG, Pa., Dec. 1 ...accine preventable deaths occur in those 65 and ol...ng to highlighted studies in the Pennsylvania Pati...ty Advisory . ,, According to the Centers for D...

(Date:12/1/2009)...le to successfully obtain information about the co...te legislation intended to improve price transpare...ncome uninsured patients, researchers received pri...tals they approached and the estimates received of...fornia law, according to the findings published on...

(Date:12/1/2009)...aths drop worldwide, but gains at risk. , ... Measles Initiative partners -- the American Re...ention, the United Nations Foundation, UNICEF, and...ce the latest global health achievement during a p...at 10:00 a.m. ET/16:00 CET. There will be time fo...

Breaking Medicine News(10 mins):Health News:UM Clinical Research Building awarded prestigious LEED Building Certification 2 Health News:Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA 2 Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 2 Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 3 Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 4 Health News:Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory 5 Health News:Hospital price transparancy laws in California fall short, study finds 2 Health News:**MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health 2

[0] UM Clinical Research Building awarded prestigious LEED Building Certification [0] Air Products Completes Sale of Polyurethane Pre-Polymers Business to COIM USA [1] Ninety Percent of All Vaccine Preventable Deaths Occur in Those 65 and Older According to Highlighted Studies in the December Patient Safety Advisory [0] Hospital price transparancy laws in California fall short, study finds [0] **MEDIA ADVISORY** Measles Initiative to Announce Major Achievement in Public Health

...ng Program Key for Massachusetts Firms, WASHINGTO...of Defense authorization bill with provisions secu...Small Business Innovation,Research (SBIR) Program ...housands of firms that participate in the,program ...

...rey Goodman Steps Down; John Walker, Board Chair, ...irman, SOUTH SAN FRANCISCO, Calif., Oct. 1 Renov...any focused on the discovery,and development of dr...President and Chief Executive Officer to,pursue an...

...EGO, Oct. 1 Amylin Pharmaceuticals,Inc. (Nasdaq: ...g,Administration (FDA) has approved the SymlinPen(...ces for administering SYMLIN(R),(pramlintide aceta...en 60 offer patients improved convenience and,accu...

... from Positive VENT Trial Presented at ERS 17th An...phasys Medical Inc.,today announced the submission... U.S. Food and Drug Administration (FDA) requestin...potentially,reversible treatment option intended t...

... who have been homeless for any period of time aft...ore problems accessing health care than those with...in the October issue of Archives of Pediatrics & A...r to have more problems accessing health care than...

...NDS RANCH, Colo., Oct. 1 Highlands Behavioral,Hea...ing of its new,Adolescent Center of Excellence for...ciated with the Adolescent Unit at Highlands Behav...enter of Excellence represents an expansion of the...

Other Medicine News:Health News:Kerry Extends, Improves Small Business Innovation Program 2 Health News:Renovis Announces Management Changes 2 Health News:Renovis Announces Management Changes 3 Health News:Renovis Announces Management Changes 4 Health News:Renovis Announces Management Changes 5 Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 2 Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 3 Health News:FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use 4 Health News:Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy 2 Health News:Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy 3 Health News:Poor health care access common among youth leaving foster system 2 Health News:Poor health care access common among youth leaving foster system 3 Health News:New Denver Area Program Developed For Teens in Crisis 2

Kerry Extends, Improves Small Business Innovation Program Renovis Announces Management Changes FDA Approves SYMLIN Pen-Injector Devices Offering Convenience and Accuracy for SYMLIN Use Emphasys Medical Announces PMA Submission for Bronchial Valve Therapy Poor health care access common among youth leaving foster system New Denver Area Program Developed For Teens in Crisis

(Date:12/1/2009)...PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE ...t licensed to Chrono Nutraceuticals LLC exclusive ...nded release dietary supplements using SCOLR,s pro...ition, SCOLR granted Chrono rights to manufacture ... on a nonexclusive basis. Chrono paid SCOLR $25,0...

(Date:12/1/2009)...1 nContact Surgical, Inc. ("nConta... minimally-invasive treatment for heart conditions...clinical trial designed to evaluate the safety and...edure, the convergent procedure, for the treatment...). This prospective, feasibility study will enrol...

(Date:12/1/2009)...1 Siemens Hearing Instruments, In...l manufacturer of hearing instruments, announced i...al,s Sound Beginnings program. The alliance will b...of the renewed partnership, Siemens is expanding t...g instruments to both children and young adults, a...

Breaking Medicine Technology:SCOLR Pharma, Inc. Licenses Dietary Supplements 2 SCOLR Pharma, Inc. Licenses Dietary Supplements 3 nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure 2 Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2 Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3 Bart Peterson to Join Lilly Leadership Team 48032 1 Bart Peterson to Join Lilly Leadership Team 48032 2 Bart Peterson to Join Lilly Leadership Team 48032 3 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 1 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 2 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 3 Low T Specialist reNEW MAN Promotes National Network of Doctors 48028 4 iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 1 iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 2 iPod Repair Site Eases Scam Worries with Unexpected Announcements 48023 3

[0] SCOLR Pharma, Inc. Licenses Dietary Supplements [0] nContact Announces Initiation of Clinical Trials for the Treatment of Paroxysmal Atrial Fibrillation Utilizing New Convergent Ablation Procedure [0] Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need

...merican Society of Clinical ... Medarex, Inc.,(Nasdaq: MEDX ) today announced u...S) results from a Phase 2 clinical study (MDX010-0...carbazine (DTIC) where 11.4%, or 4 of,35 patients,...llow-up. This,included 1 patient that experienced ...

...with Other Targeted Therapies and as Monother...irst Phase II data investigating the dual inhibiti... molecule tyrosine-kinase inhibitors (TYKERB, and...R2 (ErbB2) positive bre... and AVASTIN(R) (bevacizumab), a, monoclonal antib...

Other Medicine Technology:Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 2 Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 3 Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma 4 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 2 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 3 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 4 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 5 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 6 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 7 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 8 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 9 New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens 10

Ipilimumab Plus Chemotherapy is Associated with Prolonged Survival and Increased Disease Control Rates in Patients with Advanced Melanoma New Data Offers Insights Into the Potential Role for TYKERB(R) (Lapatinib) in Non-Cytotoxic Chemotherapy-Based Treatment Regimens

...dy method for HbA1c provides outstanding accuracy ...ement with the HPLC method(1) , Near-patient res...sults are reliable(2) , National Glycohemoglobin...as recommended by the ADA** , , , Microalbu...

Blood Coagulation Analyzer CG Series

... feature Stago's patented method of electro-mechan...erence from lipemic, icteric or other optically de...rammable and preprogrammed assays with curve stora...ctronically-linked multiple pipettor, 40-character...

MLA Electra 750 Coagulation Analyzer

Medicine Products:

DCA 2000+ Analyzer Blood Coagulation Analyzer CG Series STart 8 MLA Electra 750 Coagulation Analyzer

Immtech Reports Fiscal Third Quarter 20...(December 31 ...),Health